PCIA1 Antibody (Center) Blocking peptide
€363.00
In stock
SKU
AC-BP14094c
Background:
PCIA1 may be involved in ubiquitination and subsequent proteasomal degradation of target proteins. Component of the DDD-E2 complexes which may provide a platform for interaction with CUL4A and WD repeat proteins.
Other Names:
DET1- and DDB1-associated protein 1, Placenta cross-immune reaction antigen 1, PCIA-1, DDA1, C19orf58, PCIA1
Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP14094c was selected from the Center region of PCIA1. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Gene Name: DDA1 {ECO:0000303|PubMed:17452440, ECO:0000312|HGNC:HGNC:28360}
Gene ID: 79016
Primary Accession: Q9BW61
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
PCIA1 may be involved in ubiquitination and subsequent proteasomal degradation of target proteins. Component of the DDD-E2 complexes which may provide a platform for interaction with CUL4A and WD repeat proteins.
Other Names:
DET1- and DDB1-associated protein 1, Placenta cross-immune reaction antigen 1, PCIA-1, DDA1, C19orf58, PCIA1
Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP14094c was selected from the Center region of PCIA1. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Gene Name: DDA1 {ECO:0000303|PubMed:17452440, ECO:0000312|HGNC:HGNC:28360}
Gene ID: 79016
Primary Accession: Q9BW61
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
| Is Featured? | No |
|---|
Write Your Own Review